{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:05:42Z","timestamp":1757455542573},"reference-count":36,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2014R1A2A2A01004899"],"award-info":[{"award-number":["NRF-2014R1A2A2A01004899"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Agri-Bio Industry Technology Development Program","award":["315030-03-1-HD020"],"award-info":[{"award-number":["315030-03-1-HD020"]}]},{"name":"Ministry of Health & Welfare, Republic of Korea","award":["HI15C2928"],"award-info":[{"award-number":["HI15C2928"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.vaccine.2016.06.011","type":"journal-article","created":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T20:17:02Z","timestamp":1466021822000},"page":"3764-3772","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Protection induced by early stage vaccination with pandemic influenza virus-like particles"],"prefix":"10.1016","volume":"34","author":[{"given":"Gi-Ja","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Shi","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2016.06.011_b0005","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/nm1209","article-title":"Vaccines: past, present and future","volume":"11","author":"Plotkin","year":"2005","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2016.06.011_b0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jinf.2007.04.354","article-title":"Influenza vaccine coverage rates and perceptions on vaccination in South Korea","volume":"55","author":"Kee","year":"2007","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2016.06.011_b0015","first-page":"119","article-title":"Interim adjusted estimates of seasonal influenza vaccine effectiveness \u2013 United States, February 2013","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.vaccine.2016.06.011_b0020","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1128\/JVI.02052-06","article-title":"Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus","volume":"81","author":"Quan","year":"2007","journal-title":"J Virol"},{"issue":"50","key":"10.1016\/j.vaccine.2016.06.011_b0025","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1016\/j.vaccine.2005.07.098","article-title":"Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB\/c mice","volume":"23","author":"Pushko","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2016.06.011_b0030","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.vaccine.2008.11.011","article-title":"Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge","volume":"27","author":"Haynes","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2016.06.011_b0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1089\/vim.2005.18.244","article-title":"Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge","volume":"18","author":"Galarza","year":"2005","journal-title":"Viral Immunol"},{"issue":"19","key":"10.1016\/j.vaccine.2016.06.011_b0040","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1016\/j.vaccine.2007.01.106","article-title":"Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin","volume":"25","author":"Bright","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2016.06.011_b0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virol.2010.05.034","article-title":"Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles","volume":"405","author":"Song","year":"2010","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2016.06.011_b0050","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.vaccine.2013.11.036","article-title":"One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge","volume":"32","author":"Klausberger","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.011_b0055","first-page":"269","article-title":"Influenza virus-like particles as pandemic vaccines","volume":"333","author":"Kang","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2016.06.011_b0060","first-page":"124","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on immunization practices, United States, 2015\u201316 influenza season","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.06.011_b0065","unstructured":"Holland Jr RE, Weigel D. Effect of MEtastiM\u00ae adjuvant on the immune response in horses vaccinated with killed Kentucky\/97 equine influenza virus and challenged with the. 2012."},{"issue":"2","key":"10.1016\/j.vaccine.2016.06.011_b0070","doi-asserted-by":"crossref","first-page":"e9161","DOI":"10.1371\/journal.pone.0009161","article-title":"Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice","volume":"5","author":"Quan","year":"2010","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.vaccine.2016.06.011_b0075","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1128\/JVI.74.11.4999-5005.2000","article-title":"Induction of CD4+ T-cell-independent immunoglobulin responses by inactivated influenza virus","volume":"74","author":"Sha","year":"2000","journal-title":"J Virol"},{"issue":"26","key":"10.1016\/j.vaccine.2016.06.011_b0080","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1016\/j.vaccine.2008.03.055","article-title":"A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs","volume":"26","author":"Quan","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2016.06.011_b0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0264-410X(93)90339-Y","article-title":"Murine model for evaluation of protective immunity to influenza virus","volume":"11","author":"Novak","year":"1993","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2016.06.011_b0090","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1128\/JVI.01615-07","article-title":"Induction of heterosubtypic immunity to influenza virus by intranasal immunization","volume":"82","author":"Quan","year":"2008","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.06.011_b0095","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.virusres.2009.04.005","article-title":"Influenza vaccines based on virus-like particles","volume":"143","author":"Kang","year":"2009","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2016.06.011_b0100","unstructured":"Centers for Disease Control and Prevention (CDC). The 2009 H1N1 pandemic: summary highlights, April 2009\u2013April 2010. Website: <http:\/\/www.cdc.gov\/h1n1flu\/cdcresponse.htm> Accessed on August 2011, 2."},{"issue":"30","key":"10.1016\/j.vaccine.2016.06.011_b0105","doi-asserted-by":"crossref","first-page":"818","DOI":"10.15585\/mmwr.mm6430a3","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on immunization practices, United States, 2015\u201316 influenza season","volume":"64","author":"Grohskopf","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2016.06.011_b0110","doi-asserted-by":"crossref","first-page":"e0150146","DOI":"10.1371\/journal.pone.0150146","article-title":"Antibody persistence in adults two years after vaccination with an H1N1 2009 pandemic influenza virus-like particle vaccine","volume":"11","author":"Valero-Pacheco","year":"2016","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2016.06.011_b0115","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4161\/hv.18757","article-title":"Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic","volume":"8","author":"L\u00f3pez-Mac\u00edas","year":"2012","journal-title":"Human Vaccines Immunother"},{"issue":"5","key":"10.1016\/j.vaccine.2016.06.011_b0120","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1080\/21645515.2015.1016675","article-title":"Lessons learned from successful human vaccines: delineating key epitopes by dissecting the capsid proteins","volume":"11","author":"Zhang","year":"2015","journal-title":"Human Vaccines Immunother"},{"issue":"7","key":"10.1016\/j.vaccine.2016.06.011_b0125","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.molmed.2010.05.002","article-title":"Alternative influenza vaccines made by insect cells","volume":"16","author":"Krammer","year":"2010","journal-title":"Trends Mol Med"},{"issue":"12","key":"10.1016\/j.vaccine.2016.06.011_b0130","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections","volume":"166","author":"Huber","year":"2001","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2016.06.011_b0135","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/JVI.02128-06","article-title":"Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity","volume":"81","author":"Jayasekera","year":"2007","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.06.011_b0140","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.virol.2006.05.008","article-title":"Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components","volume":"352","author":"Mozdzanowska","year":"2006","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.vaccine.2016.06.011_b0145","doi-asserted-by":"crossref","first-page":"e51559","DOI":"10.1371\/journal.pone.0051559","article-title":"Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity","volume":"7","author":"Margine","year":"2012","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.vaccine.2016.06.011_b0150","doi-asserted-by":"crossref","first-page":"9944","DOI":"10.1128\/JVI.73.12.9944-9951.1999","article-title":"Baculovirus stimulates antiviral effects in mammalian cells","volume":"73","author":"Gronowski","year":"1999","journal-title":"J Virol"},{"issue":"15","key":"10.1016\/j.vaccine.2016.06.011_b0155","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1128\/JVI.00679-09","article-title":"Baculovirus induces type I interferon production through toll-like receptor-dependent and -independent pathways in a cell-type-specific manner","volume":"83","author":"Abe","year":"2009","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.06.011_b0160","doi-asserted-by":"crossref","first-page":"e4667","DOI":"10.1371\/journal.pone.0004667","article-title":"Induction of long-term protective immune responses by influenza H5N1 virus-like particles","volume":"4","author":"Kang","year":"2009","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2016.06.011_b0165","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1086\/649228","article-title":"Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles","volume":"201","author":"Kim","year":"2010","journal-title":"J Infect Dis"},{"issue":"26","key":"10.1016\/j.vaccine.2016.06.011_b0170","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1016\/j.vaccine.2008.03.055","article-title":"A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs","volume":"26","author":"Quan","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2016.06.011_b0175","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1017\/S0950268800001539","article-title":"Isotype-specific antibody responses to foot-and-mouth disease virus in sera and secretions of \u201ccarrier\u2019 and \u201cnon-carrier\u2019 cattle","volume":"117","author":"Salt","year":"1996","journal-title":"Epidemiol Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2016.06.011_b0180","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0264-410X(97)86180-4","article-title":"Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission","volume":"16","author":"Salt","year":"1998","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16304108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16304108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T09:37:42Z","timestamp":1600767462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16304108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":36,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0264410X16304108"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.06.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection induced by early stage vaccination with pandemic influenza virus-like particles","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}